Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer

Cancer Research

Volumn 67, Issue 6, 2007, Pages 2568-2576

  Hosokawa, Masayo ^a,b   Takehara, Akio ^a   Matsuda, Koichi ^a   Eguchi, Hidetoshi ^c   Ohigashi, Hiroaki ^c   Ishikawa, Osamu ^c   Shinomura, Yasuhisa ^b   Imai, Kohzoh ^b   Nakamura, Yusuke ^a   Nakagawa, Hidewaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; COMPLEMENTARY DNA; CYCLINE; DOXORUBICIN; DOXYCYCLINE; PROTEIN P15; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DNA REPLICATION; DRUG INHIBITION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; STUDENT T TEST; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELL GROWTH PROCESSES; CELL TRANSFORMATION, NEOPLASTIC; DNA REPLICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PANCREATIC NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 34047247407     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-4356     Document Type: Article

References (24)

1. DiMAgno EP, Reber HA, Tempera MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999;117:1464-84.
2. Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 2005;128:1626-41.
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
4. Nakamura T, Furukawa Y, Nakagawa H, et al. Genomewide cDNA microarray analysis of gene-expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 2004;23: 2385-400.
5. Peiwen Y, Huang B, Shen M, et al. p15 PAF, a novel PCNA associated factor with increased expression in tumor tissues. Oncogene 2001;20:484-9.
6. Prelich G, Kostura M, Marshak DR, et al. The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro. Nature 1987; 326:471-5.
7. Wyman C, Botchan M. DNA replication. A familiar ring to DNA polymerase processivity. Curr Biol 1997;5:334-7.
8. Warbick E. The puzzle of PCNA's many partners. Bioassays 2000;22:195-1006.
9. Krishna TS, Kong XP, Gary S, Burgers PM, Kuriyan J. Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA. Cell 1994;79:1233-43.
10. Jonsson ZO, Hindges R, Hubscher U. Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen. EMBO J 1998;17:2412-25.
11. Haitel A, Wiener HG, Migschitz B, Marberger M, Susani M. Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas? Am J Clin Pathol 1997;107: 229-35.
12. Simpson F, Lammerts van Bueren, Butterfield N, et al. The PCNA-associated factor KIAA0101/p15PAF binds the potential tumor suppressor product p33ING1b. Exp Cell Res 2006;31:73-85.
13. 1 arrest in human cancer cells. Cancer Res 1995;55:5187-90.
14. Taniuchi K, Nakagawa H, Nakamura T, et al. Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of Disc Large Homolog 5, can attenuate growth of pancreatic cancer cells. Cancer Res 2005;65:105-12.
15. van de Wetering M, Oving I, Muncan V, et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003; 4:609-15.
16. Noguchi H, Matsushita M, Okitsu T, et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 2004;10:305-9.
17. Shan B, Morris GF. Binding sequence-dependent regulation of the human proliferating cell nuclear antigen promoter by p53. Exp Cell Res 2005;305: 10-22.
18. Li B, Lee MY. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. J Biol Chem 2001;276:29729-39.
19. Christmann M, Tomicic MT, Origer J, Kaina B. Fen1 is induced p53 dependently and involved in the recovery from UV-light-induced replication inhibition. Oncogene 2005;24:8304-13.
20. Nakamura Y. Isolation of p53-target genes and their functional analysis. Cancer Sci 2004;95:7-11.
21. Kikuchi T, Daigo Y, Katagiri T, et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 2003;22:2192-205.
22. Ashida S, Nakagawa H, Katagiri T, et al. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res 2004;64:5963-72.
23. Kontopidis G, Wu S, Zheleva DI, et al. Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibition design. Proc Natl Acad Sci U S A 2005;102:1871-6.
24. Walensky LD,Kung AL, Escher I, et al. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 2004;305:1446-70.